Morepen Laboratories, 500288, MOREPENLAB Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

5,624.74
29.83
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,675.05
0.19%
4.07

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.73
3.14
2.22

EBITDA CAGR (%)

10 Years
5 Years
3 Years

7.43
-1.67
-4.56

PAT CAGR (%)

10 Years
5 Years
3 Years

14.91
-1.37
-0.45

P:E (Median)

8 Years
5 Years
3 Years

27.13
29.01
29.70

P:BV (Average)

8 Years
5 Years
3 Years

3.27
2.88
2.97

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.68
17.18
18.73

Earnings Forecasts:

(Updated: 31-10-2026)

Description 2026 2027 2028 2029
Adj EPS 1.73 - - -
P/E Ratio 59.14 - - -
Revenue 1801.13 - - -
EBITDA 125.63 - - -
Net Income 94.88 - - -
ROA 5.11 - - -
P/B Ratio 4.50 - - -
ROE 7.9 - - -
FCFF -69.3 - - -
FCFF Yield -1.06 - - -
Net Debt 117.29 - - -
BVPS 22.75 - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 678.00 369.53 83.48% 541.04 391.28 38.27% 462.81 381.94 21.17% 457.57 403.25 13.47%
Expenses 567.98 341.60 66.27% 461.44 372.33 23.93% 439.50 351.78 24.94% 415.68 371.68 11.84%
EBITDA 110.02 27.92 294.05% 79.60 18.95 320.05% 23.31 30.16 -22.71% 41.89 31.58 32.65%
EBIDTM 16.23% 7.56% 14.71% 4.84% 5.04% 7.90% 9.15% 7.83%
Other Income 8.43 4.65 81.29% 5.31 4.09 29.83% 8.82 3.14 180.89% 3.93 4.87 -19.30%
Interest 5.10 4.11 24.09% 4.78 3.81 25.46% 3.87 3.74 3.48% 4.31 1.27 239.37%
Depreciation 9.70 10.70 -9.35% 7.98 7.88 1.27% 0.63 12.25 -94.86% 10.09 4.81 109.77%
PBT 103.65 18.86 449.58% 72.15 11.35 535.68% 27.63 17.30 59.71% 31.42 30.38 3.42%
Tax 25.78 4.49 474.16% 18.15 3.29 451.67% 7.50 5.39 39.15% 7.93 7.69 3.12%
PAT 77.87 14.38 441.52% 54.00 8.06 569.98% 20.12 11.91 68.93% 23.50 22.69 3.57%
PATM 11.49% 3.89% 9.98% 2.06% 4.35% 3.12% 5.13% 5.63%
EPS 1.42 0.26 446.15% 0.99 0.15 560.00% 0.37 0.22 68.18% 0.43 0.41 4.88%

Description Sep 26 Sep 25 Var% Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var%
Net Sales 746.50 411.58 81.37% 570.13 425.24 34.07% 484.72 465.85 4.05% 484.16 452.78 6.93%
Expenses 623.38 380.88 63.67% 487.59 401.07 21.57% 460.27 423.61 8.65% 437.84 416.64 5.09%
EBITDA 123.12 30.70 301.04% 82.53 24.17 241.46% 24.45 42.24 -42.12% 46.32 36.14 28.17%
EBIDTM 16.49% 7.46% 14.48% 5.68% 5.04% 9.07% 9.57% 7.98%
Other Income 8.68 4.64 87.07% 5.18 4.41 17.46% 8.46 4.61 83.51% 3.81 5.34 -28.65%
Interest 5.19 4.18 24.16% 4.84 4.04 19.80% 3.88 4.67 -16.92% 4.32 1.34 222.39%
Depreciation 10.07 11.28 -10.73% 8.35 9.03 -7.53% 5.75 16.47 -65.09% 10.38 4.93 110.55%
PBT 116.54 45.69 155.07% 74.53 15.52 380.22% 23.29 25.71 -9.41% 35.42 35.20 0.62%
Tax 27.65 4.65 494.62% 18.18 4.11 342.34% 7.59 5.40 40.56% 7.93 8.52 -6.92%
PAT 88.89 41.04 116.59% 56.35 11.40 394.30% 15.70 20.31 -22.70% 27.49 26.69 3.00%
PATM 11.91% 9.97% 9.88% 2.68% 3.24% 4.36% 5.68% 5.89%
EPS 1.62 0.75 116.00% 1.03 0.20 415.00% 0.29 0.37 -21.62% 0.50 0.49 2.04%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,139.42 1,681.19 1,554.54 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24 560.83 547.51 Net Sales Growth 38.38% 8.15% 1.10% 14.84% -7.62% 30.28% 40.46% 10.42% 27.89% 2.43% Cost Of Goods Sold 1,270.17 1,004.40 929.43 904.73 847.50 921.58 691.36 487.87 448.98 335.30 328.24 Gross Profit 869.25 676.79 625.10 632.87 491.39 527.68 421.06 304.13 268.26 225.52 219.27 GP Margin 40.63% 40.26% 40.21% 41.16% 36.70% 36.41% 37.85% 38.40% 37.40% 40.21% 40.05% Total Expenditure 1,884.60 1,569.12 1,401.12 1,375.77 1,261.61 1,320.13 1,000.05 727.52 652.22 500.56 487.02 Power & Fuel Cost - 44.90 40.62 34.09 23.78 18.93 13.00 12.56 13.18 11.08 9.84 % Of Sales - 2.67% 2.61% 2.22% 1.78% 1.31% 1.17% 1.59% 1.84% 1.98% 1.80% Employee Cost - 206.28 177.22 160.28 146.19 150.00 123.20 98.07 84.74 68.22 60.79 % Of Sales - 12.27% 11.40% 10.42% 10.92% 10.35% 11.07% 12.38% 11.81% 12.16% 11.10% Manufacturing Exp. - 125.24 102.33 95.50 91.66 98.96 66.82 48.90 31.27 16.21 15.05 % Of Sales - 7.45% 6.58% 6.21% 6.85% 6.83% 6.01% 6.17% 4.36% 2.89% 2.75% General & Admin Exp. - 66.22 60.29 58.56 50.41 35.93 29.69 31.93 31.21 24.35 21.53 % Of Sales - 3.94% 3.88% 3.81% 3.77% 2.48% 2.67% 4.03% 4.35% 4.34% 3.93% Selling & Distn. Exp. - 90.41 70.00 99.15 84.91 44.90 44.09 35.75 31.72 29.13 29.04 % Of Sales - 5.38% 4.50% 6.45% 6.34% 3.10% 3.96% 4.51% 4.42% 5.19% 5.30% Miscellaneous Exp. - 31.68 21.23 23.47 17.16 49.84 31.89 12.45 11.11 16.26 29.04 % Of Sales - 1.88% 1.37% 1.53% 1.28% 3.44% 2.87% 1.57% 1.55% 2.90% 4.11% EBITDA 254.82 112.07 153.42 161.82 77.27 129.14 112.37 64.47 65.02 60.27 60.49 EBITDA Margin 11.91% 6.67% 9.87% 10.52% 5.77% 8.91% 10.10% 8.14% 9.07% 10.75% 11.05% Other Income 26.49 21.50 15.72 12.57 5.76 20.03 11.77 9.42 3.67 3.54 3.72 Interest 18.06 16.10 7.10 3.51 1.98 2.43 1.79 1.97 2.07 4.29 7.47 Depreciation 28.40 29.31 24.44 21.90 18.01 21.19 28.11 34.43 38.01 33.40 33.56 PBT 234.85 88.17 137.59 148.98 63.04 125.54 94.25 37.48 28.61 26.12 23.17 Tax 59.36 23.21 36.01 38.04 16.80 24.48 0.00 5.15 0.00 0.00 0.00 Tax Rate 25.28% 26.00% 26.17% 25.53% 26.65% 19.50% 0.00% 13.74% 0.00% 0.00% 0.00% PAT 175.49 66.06 101.58 110.94 46.24 101.06 94.25 32.33 28.61 26.12 23.17 PAT before Minority Interest 175.49 66.06 101.58 110.94 46.24 101.06 94.25 32.33 28.61 26.12 23.17 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.20% 3.93% 6.53% 7.22% 3.45% 6.97% 8.47% 4.08% 3.99% 4.66% 4.23% PAT Growth 207.66% -34.97% -8.44% 139.92% -54.25% 7.23% 191.52% 13.00% 9.53% 12.73% EPS 3.20 1.21 1.85 2.02 0.84 1.84 1.72 0.59 0.52 0.48 0.42

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,285.51 1,805.69 1,811.58 1,690.43 1,417.53 1,546.83 1,188.06 853.07 768.54 606.51 595.47 Net Sales Growth 30.20% -0.33% 7.17% 19.25% -8.36% 30.20% 39.27% 11.00% 26.72% 1.85% Cost Of Goods Sold 1,304.41 1,066.46 1,113.11 1,016.87 900.22 980.35 735.29 524.19 479.12 361.28 358.35 Gross Profit 981.10 739.24 698.47 673.56 517.31 566.47 452.77 328.87 289.42 245.23 237.12 GP Margin 42.93% 40.94% 38.56% 39.85% 36.49% 36.62% 38.11% 38.55% 37.66% 40.43% 39.82% Total Expenditure 2,009.08 1,680.06 1,637.51 1,531.81 1,338.00 1,410.15 1,069.54 784.55 701.02 541.78 534.09 Power & Fuel Cost - 44.90 40.62 34.09 23.78 18.93 13.00 12.56 13.18 11.08 9.84 % Of Sales - 2.49% 2.24% 2.02% 1.68% 1.22% 1.09% 1.47% 1.71% 1.83% 1.65% Employee Cost - 232.74 208.91 181.47 154.68 164.25 135.59 109.91 95.36 76.53 69.69 % Of Sales - 12.89% 11.53% 10.74% 10.91% 10.62% 11.41% 12.88% 12.41% 12.62% 11.70% Manufacturing Exp. - 125.33 102.62 95.75 91.70 98.99 67.21 48.92 31.28 16.21 22.36 % Of Sales - 6.94% 5.66% 5.66% 6.47% 6.40% 5.66% 5.73% 4.07% 2.67% 3.76% General & Admin Exp. - 73.16 67.17 66.63 55.44 42.38 34.71 36.47 36.14 28.52 18.11 % Of Sales - 4.05% 3.71% 3.94% 3.91% 2.74% 2.92% 4.28% 4.70% 4.70% 3.04% Selling & Distn. Exp. - 98.98 79.99 109.98 93.01 53.58 49.66 40.11 32.73 30.04 25.79 % Of Sales - 5.48% 4.42% 6.51% 6.56% 3.46% 4.18% 4.70% 4.26% 4.95% 4.33% Miscellaneous Exp. - 38.50 25.09 27.02 19.17 51.67 34.08 12.39 13.20 18.11 25.79 % Of Sales - 2.13% 1.38% 1.60% 1.35% 3.34% 2.87% 1.45% 1.72% 2.99% 5.03% EBITDA 276.42 125.63 174.07 158.62 79.53 136.68 118.52 68.52 67.52 64.73 61.38 EBITDA Margin 12.09% 6.96% 9.61% 9.38% 5.61% 8.84% 9.98% 8.03% 8.79% 10.67% 10.31% Other Income 26.13 21.31 18.36 13.97 6.13 20.10 12.07 9.48 3.67 3.72 3.72 Interest 18.23 16.41 8.34 3.71 1.98 2.43 1.79 1.98 2.11 4.36 7.56 Depreciation 34.55 36.43 28.98 33.47 27.93 27.64 30.28 36.91 39.90 34.32 33.90 PBT 249.78 94.09 155.11 135.42 55.76 126.70 98.51 39.11 29.18 29.77 23.63 Tax 61.35 24.27 37.09 38.80 17.08 25.02 1.42 5.53 0.34 0.00 0.00 Tax Rate 24.56% 20.24% 23.91% 28.65% 30.63% 19.75% 1.44% 14.14% 1.17% 0.00% 0.00% PAT 188.43 94.88 118.03 96.16 38.68 101.68 97.09 33.58 28.85 29.59 23.63 PAT before Minority Interest 188.48 95.65 118.02 96.62 38.68 101.68 97.09 33.58 28.84 29.77 23.63 Minority Interest 0.05 -0.77 0.01 -0.46 0.00 0.00 0.00 0.00 0.01 -0.18 0.00 PAT Margin 8.24% 5.25% 6.52% 5.69% 2.73% 6.57% 8.17% 3.94% 3.75% 4.88% 3.97% PAT Growth 89.49% -19.61% 22.74% 148.60% -61.96% 4.73% 189.13% 16.40% -2.50% 25.22% EPS 3.44 1.73 2.15 1.75 0.71 1.86 1.77 0.61 0.53 0.54 0.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,242.76 1,181.50 889.02 780.11 598.17 444.97 307.25 277.46 250.56 224.34 Share Capital 109.58 109.58 102.23 102.23 95.56 89.96 89.96 89.96 89.96 89.96 Total Reserves 1,133.17 1,071.92 786.80 677.89 476.36 311.26 217.29 187.50 160.60 134.38 Non-Current Liabilities 187.50 78.15 37.65 34.45 32.41 26.89 25.36 21.11 17.87 15.28 Secured Loans 4.49 5.76 3.36 0.93 1.32 0.83 0.92 1.79 2.70 0.94 Unsecured Loans 128.37 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 34.41 36.40 31.60 28.87 26.64 24.01 22.38 17.85 13.45 12.69 Current Liabilities 346.29 461.56 352.63 290.98 402.69 375.63 329.38 320.82 322.21 308.19 Trade Payables 236.84 338.41 267.43 213.10 217.32 192.33 158.38 157.08 164.89 116.20 Other Current Liabilities 64.83 59.51 38.66 39.79 159.63 163.93 157.39 153.61 156.05 190.70 Short Term Borrowings 36.59 46.04 23.49 23.18 16.13 15.32 11.36 8.99 0.00 0.00 Short Term Provisions 8.03 17.60 23.05 14.91 9.61 4.05 2.25 1.14 1.26 1.29 Total Liabilities 1,776.55 1,721.21 1,279.30 1,105.54 1,033.27 847.49 661.99 619.39 590.64 547.81 Net Block 402.63 365.87 216.54 170.82 156.11 144.02 134.84 152.59 182.10 191.29 Gross Block 664.91 648.76 477.36 512.07 479.46 516.17 641.54 777.14 890.30 922.26 Accumulated Depreciation 262.27 282.88 260.83 341.25 323.35 372.14 506.70 624.55 708.20 730.96 Non Current Assets 669.19 614.42 436.40 374.69 356.50 354.71 313.73 336.06 363.54 369.25 Capital Work in Progress 8.22 28.34 24.45 17.01 14.15 1.96 0.00 0.00 0.00 0.00 Non Current Investment 104.14 127.17 126.18 117.84 117.79 118.78 118.78 117.69 117.69 117.69 Long Term Loans & Adv. 155.47 92.81 68.99 68.74 68.17 89.67 59.83 65.49 63.47 59.41 Other Non Current Assets -1.27 0.23 0.24 0.28 0.28 0.27 0.28 0.28 0.27 0.85 Current Assets 918.79 1,106.78 842.91 730.85 676.76 492.79 348.26 283.33 227.11 178.56 Current Investments 5.91 77.81 0.00 0.00 0.00 0.00 0.00 0.02 0.22 0.00 Inventories 154.26 286.39 220.15 211.35 258.25 169.61 132.47 90.84 73.94 62.50 Sundry Debtors 333.19 293.75 316.89 255.47 221.87 155.52 121.41 121.96 110.22 83.10 Cash & Bank 46.96 46.33 50.48 55.90 45.55 66.98 38.03 31.98 5.70 6.75 Other Current Assets 378.47 71.31 16.27 4.97 151.09 100.68 56.35 38.52 37.02 26.22 Short Term Loans & Adv. 357.42 331.19 239.12 203.16 146.02 90.88 50.45 30.80 32.14 22.91 Net Current Assets 572.50 645.23 490.27 439.87 274.07 117.16 18.88 -37.49 -95.10 -129.63 Total Assets 1,587.98 1,721.20 1,279.31 1,105.54 1,033.26 847.50 661.99 619.39 590.65 547.81

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,246.44 1,156.23 847.23 752.91 578.56 424.75 284.06 253.09 225.94 196.26 Share Capital 109.58 109.58 102.23 102.23 95.56 89.96 89.96 89.96 89.96 89.96 Total Reserves 1,136.85 1,046.65 745.00 650.68 456.75 291.04 194.10 163.13 135.98 106.30 Non-Current Liabilities 198.73 90.49 43.93 36.88 35.50 30.06 28.42 23.38 20.20 17.80 Secured Loans 4.49 5.76 3.36 0.93 1.32 0.83 0.92 1.83 2.95 1.38 Unsecured Loans 129.11 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 41.24 39.85 33.82 29.74 28.24 25.39 23.82 19.01 14.42 13.59 Current Liabilities 490.30 500.65 402.04 321.16 456.46 403.80 351.44 339.17 340.12 324.86 Trade Payables 317.24 363.30 295.03 226.88 258.12 208.85 172.30 168.15 174.88 124.88 Other Current Liabilities 106.47 71.72 58.51 54.86 169.97 174.38 165.06 160.64 163.90 198.65 Short Term Borrowings 36.95 46.04 23.49 23.18 16.13 15.32 11.36 8.99 0.00 0.00 Short Term Provisions 29.64 19.60 25.02 16.24 12.24 5.25 2.72 1.39 1.33 1.33 Total Liabilities 1,936.12 1,778.10 1,293.20 1,110.49 1,070.06 858.15 663.46 615.18 585.81 538.29 Net Block 513.00 488.51 307.35 266.97 251.80 224.52 216.37 236.21 264.29 271.80 Gross Block 796.70 828.38 620.63 656.24 613.25 628.32 752.55 887.76 997.60 1,026.96 Accumulated Depreciation 283.70 339.87 313.28 389.27 361.45 403.79 536.18 651.55 733.31 755.15 Non Current Assets 772.51 618.73 404.16 354.33 335.75 331.36 291.29 315.71 342.37 346.34 Capital Work in Progress 21.55 28.34 24.45 17.01 14.15 1.96 0.00 0.00 0.00 0.00 Non Current Investment 101.29 7.17 1.30 0.00 0.00 1.08 1.08 0.00 0.00 0.00 Long Term Loans & Adv. 136.39 94.47 70.82 70.07 69.53 103.52 73.55 79.22 77.81 73.69 Other Non Current Assets 0.27 0.23 0.24 0.28 0.28 0.27 0.28 0.28 0.27 0.85 Current Assets 1,163.61 1,159.37 889.04 756.16 734.30 526.79 372.18 299.47 243.44 191.95 Current Investments 22.87 77.81 0.00 0.00 0.00 0.00 0.00 0.02 0.22 0.00 Inventories 271.83 299.96 248.59 228.89 275.85 175.33 138.48 94.20 76.89 64.66 Sundry Debtors 333.14 324.76 324.94 263.25 250.64 181.98 137.68 133.75 121.85 92.95 Cash & Bank 68.83 49.36 52.12 56.31 45.97 67.89 38.88 32.21 5.95 7.59 Other Current Assets 466.95 71.51 16.44 7.15 161.83 101.59 57.14 39.29 38.53 26.74 Short Term Loans & Adv. 360.43 335.97 246.96 200.58 156.54 91.58 51.16 31.43 33.61 23.43 Net Current Assets 673.31 658.72 487.00 435.00 277.84 122.99 20.73 -39.70 -96.68 -132.92 Total Assets 1,936.12 1,778.10 1,293.20 1,110.49 1,070.05 858.15 663.47 615.18 585.81 538.29

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 20.47 29.08 77.36 -102.12 -68.87 49.31 10.86 14.58 61.25 49.24 PBT 89.26 137.59 148.98 63.04 125.54 94.25 37.48 28.61 26.12 22.55 Adjustment 51.38 31.93 22.70 18.01 13.02 29.63 34.23 38.36 37.86 40.92 Changes in Working Capital -95.96 -104.37 -56.96 -166.90 -183.04 -74.56 -55.33 -52.40 -2.72 -14.23 Cash after chg. in Working capital 44.68 65.15 114.72 -85.84 -44.47 49.31 16.38 14.58 61.25 49.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -24.21 -36.07 -37.36 -16.27 -24.39 0.00 -5.52 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -119.02 -280.42 -83.60 -36.20 -22.64 -69.09 -12.08 -10.34 -24.28 -14.67 Net Fixed Assets 3.97 -175.29 27.27 -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 Net Investments 94.93 -78.80 -8.34 -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 Others -217.92 -26.33 -102.53 -0.68 -48.15 -192.50 -146.61 -123.70 -56.02 -6.59 Cash from Financing Activity 97.12 260.47 0.28 144.20 66.41 47.46 4.65 -0.35 -37.67 -31.29 Net Cash Inflow / Outflow -1.43 9.12 -5.96 5.88 -25.09 27.68 3.43 3.89 -0.69 3.29 Opening Cash & Equivalents 24.43 15.30 21.26 15.38 40.47 12.79 9.36 5.47 6.16 2.87 Closing Cash & Equivalent 23.00 24.43 15.30 21.26 15.38 40.47 12.79 9.36 5.47 6.16

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 32.64 32.06 73.37 -91.17 -60.24 50.83 11.02 17.37 63.41 40.73 PBT 119.92 155.11 135.42 55.76 126.70 98.51 39.11 29.18 29.77 23.04 Adjustment 33.46 37.79 34.20 27.90 19.46 31.96 36.63 40.32 38.64 41.40 Changes in Working Capital -95.46 -123.69 -58.12 -158.28 -181.47 -78.18 -58.84 -51.78 -5.00 -23.72 Cash after chg. in Working capital 57.92 69.21 111.49 -74.62 -35.31 52.29 16.89 17.71 63.41 40.73 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -25.28 -37.15 -38.12 -16.55 -24.93 -1.46 -5.88 -0.34 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.42 -321.51 -83.30 -46.51 -31.68 -70.35 -12.46 -13.05 -26.93 -13.60 Net Fixed Assets 3.97 -175.29 27.27 -35.47 24.52 123.41 135.60 113.16 31.96 -8.08 Net Investments 94.93 -78.80 -8.34 -0.05 0.99 0.00 -1.07 0.20 -0.22 0.00 Others -222.32 -67.42 -102.23 -10.99 -57.19 -193.76 -146.99 -126.41 -58.67 -5.52 Cash from Financing Activity 97.40 299.89 5.20 143.54 66.33 47.27 5.49 -0.44 -37.77 -23.72 Net Cash Inflow / Outflow 6.62 10.44 -4.72 5.86 -25.58 27.75 4.04 3.88 -1.29 3.40 Opening Cash & Equivalents 27.38 16.95 21.67 15.80 41.39 13.64 9.60 5.72 7.00 3.60 Closing Cash & Equivalent 31.19 27.38 16.95 21.67 15.80 41.39 13.64 9.60 5.72 7.00

Financial Ratios

Consolidated /

Standalone

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 22.68 21.56 17.39 15.26 11.97 8.92 6.83 6.17 5.57 4.99 ROA 3.64% 6.77% 9.30% 4.32% 10.75% 12.49% 5.05% 4.73% 4.59% 4.28% ROE 5.45% 9.81% 13.29% 6.84% 20.77% 26.61% 11.06% 10.84% 11.00% 10.69% ROCE 7.81% 13.29% 17.71% 9.15% 23.73% 24.54% 10.82% 7.74% 9.26% 9.17% Fixed Asset Turnover 2.56 2.76 3.11 2.70 2.91 1.92 1.12 0.86 0.62 0.60 Receivable days 68.06 71.69 67.93 65.07 47.52 45.43 56.08 59.08 62.91 54.48 Inventory Days 47.83 59.47 51.22 64.01 53.88 49.56 51.46 41.93 44.40 34.44 Payable days 104.52 118.96 96.93 92.69 81.12 92.58 79.07 88.97 104.24 84.35 Cash Conversion Cycle 11.37 12.19 22.22 36.39 20.28 2.41 28.47 12.04 3.07 4.58 Total Debt/Equity 0.16 0.07 0.03 0.03 0.03 0.04 0.04 0.47 0.53 0.22 Interest Cover 6.55 20.37 43.45 32.83 52.75 53.71 20.05 14.82 7.08 4.10

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 22.75 21.10 16.58 14.73 11.56 8.47 6.32 5.63 5.02 4.36 ROA 5.15% 7.68% 8.04% 3.55% 10.55% 12.76% 5.25% 4.80% 5.30% 4.45% ROE 7.96% 11.78% 12.08% 5.93% 21.79% 29.20% 12.50% 12.04% 14.10% 12.54% ROCE 10.19% 15.48% 16.82% 8.40% 24.86% 27.13% 12.05% 10.01% 14.05% 10.18% Fixed Asset Turnover 2.22 2.50 2.65 2.23 2.49 1.72 1.04 0.82 0.60 0.58 Receivable days 66.49 65.45 63.50 66.16 51.04 49.10 58.07 60.70 64.63 55.44 Inventory Days 57.79 55.26 51.55 64.98 53.23 48.20 49.78 40.63 42.59 32.73 Payable days 116.46 107.94 93.67 98.32 86.93 94.60 79.06 88.85 103.38 82.97 Cash Conversion Cycle 7.82 12.78 21.38 32.82 17.35 2.71 28.78 12.48 3.85 5.20 Total Debt/Equity 0.16 0.07 0.03 0.03 0.03 0.04 0.05 0.52 0.06 0.25 Interest Cover 8.31 19.59 37.50 29.15 53.22 56.09 20.71 14.83 7.83 4.13

Top Investors:

pinfold overseas limited

morepen laboratories limited

Annual Reports:

News Update:

Morepen Laboratories - Quarterly Results
28th Oct 2026, 00:00 AM

Read More
Morepen strengthens integrated CDMO capabilities with first U.S. ANDA submission
28th Sep 2026, 11:39 AM

The company has submitted ANDA to USFDA for Sitagliptin Tablets USP in 25 mg, 50 mg and 100 mg strengths
Read More
Morepen Lab expands reactor capacity for API, CDMO
7th Sep 2026, 11:14 AM

The company has completed the first phase of its manufacturing capacity expansion program
Read More

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 500288 | NSE: MOREPENLAB

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Morepen Laboratories Ltd.

Pharmaceuticals & Drugs - API

BSE: 500288 | NSE: MOREPENLAB

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: